Orchestra BioMed Holdings, Inc. Annual Return On Equity in % from 2022 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Orchestra BioMed Holdings, Inc. quarterly/annual Return On Equity history and growth rate from 2022 to 2023.
  • Orchestra BioMed Holdings, Inc. Return On Equity for the quarter ending September 30, 2024 was -107 %, a 86.7% decline year-over-year.
  • Orchestra BioMed Holdings, Inc. annual Return On Equity for 2023 was -58.3 %, a 20.4% increase from 2022.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -58.3 +14.9 +20.4% Jan 1, 2023 Dec 31, 2023
2022 -73.2 Jan 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.